MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes

<p>Abstract</p> <p>Background</p> <p>The binding of peptide fragments of antigens to class II MHC is a crucial step in initiating a helper T cell immune response. The identification of such peptide epitopes has potential applications in vaccine design and in better unde...

Full description

Bibliographic Details
Main Authors: Mittelmann Hans D, Bordner Andrew J
Format: Article
Language:English
Published: BMC 2010-09-01
Series:BMC Bioinformatics
Online Access:http://www.biomedcentral.com/1471-2105/11/482
id doaj-cbaecd8fd34942e2bd8373c642c67497
record_format Article
spelling doaj-cbaecd8fd34942e2bd8373c642c674972020-11-25T01:06:23ZengBMCBMC Bioinformatics1471-21052010-09-0111148210.1186/1471-2105-11-482MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypesMittelmann Hans DBordner Andrew J<p>Abstract</p> <p>Background</p> <p>The binding of peptide fragments of antigens to class II MHC is a crucial step in initiating a helper T cell immune response. The identification of such peptide epitopes has potential applications in vaccine design and in better understanding autoimmune diseases and allergies. However, comprehensive experimental determination of peptide-MHC binding affinities is infeasible due to MHC diversity and the large number of possible peptide sequences. Computational methods trained on the limited experimental binding data can address this challenge. We present the MultiRTA method, an extension of our previous single-type RTA prediction method, which allows the prediction of peptide binding affinities for multiple MHC allotypes not used to train the model. Thus predictions can be made for many MHC allotypes for which experimental binding data is unavailable.</p> <p>Results</p> <p>We fit MultiRTA models for both HLA-DR and HLA-DP using large experimental binding data sets. The performance in predicting binding affinities for novel MHC allotypes, not in the training set, was tested in two different ways. First, we performed leave-one-allele-out cross-validation, in which predictions are made for one allotype using a model fit to binding data for the remaining MHC allotypes. Comparison of the HLA-DR results with those of two other prediction methods applied to the same data sets showed that MultiRTA achieved performance comparable to NetMHCIIpan and better than the earlier TEPITOPE method. We also directly tested model transferability by making leave-one-allele-out predictions for additional experimentally characterized sets of overlapping peptide epitopes binding to multiple MHC allotypes. In addition, we determined the applicability of prediction methods like MultiRTA to other MHC allotypes by examining the degree of MHC variation accounted for in the training set. An examination of predictions for the promiscuous binding CLIP peptide revealed variations in binding affinity among alleles as well as potentially distinct binding registers for HLA-DR and HLA-DP. Finally, we analyzed the optimal MultiRTA parameters to discover the most important peptide residues for promiscuous and allele-specific binding to HLA-DR and HLA-DP allotypes.</p> <p>Conclusions</p> <p>The MultiRTA method yields competitive performance but with a significantly simpler and physically interpretable model compared with previous prediction methods. A MultiRTA prediction webserver is available at <url>http://bordnerlab.org/MultiRTA</url>.</p> http://www.biomedcentral.com/1471-2105/11/482
collection DOAJ
language English
format Article
sources DOAJ
author Mittelmann Hans D
Bordner Andrew J
spellingShingle Mittelmann Hans D
Bordner Andrew J
MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
BMC Bioinformatics
author_facet Mittelmann Hans D
Bordner Andrew J
author_sort Mittelmann Hans D
title MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
title_short MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
title_full MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
title_fullStr MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
title_full_unstemmed MultiRTA: A simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes
title_sort multirta: a simple yet reliable method for predicting peptide binding affinities for multiple class ii mhc allotypes
publisher BMC
series BMC Bioinformatics
issn 1471-2105
publishDate 2010-09-01
description <p>Abstract</p> <p>Background</p> <p>The binding of peptide fragments of antigens to class II MHC is a crucial step in initiating a helper T cell immune response. The identification of such peptide epitopes has potential applications in vaccine design and in better understanding autoimmune diseases and allergies. However, comprehensive experimental determination of peptide-MHC binding affinities is infeasible due to MHC diversity and the large number of possible peptide sequences. Computational methods trained on the limited experimental binding data can address this challenge. We present the MultiRTA method, an extension of our previous single-type RTA prediction method, which allows the prediction of peptide binding affinities for multiple MHC allotypes not used to train the model. Thus predictions can be made for many MHC allotypes for which experimental binding data is unavailable.</p> <p>Results</p> <p>We fit MultiRTA models for both HLA-DR and HLA-DP using large experimental binding data sets. The performance in predicting binding affinities for novel MHC allotypes, not in the training set, was tested in two different ways. First, we performed leave-one-allele-out cross-validation, in which predictions are made for one allotype using a model fit to binding data for the remaining MHC allotypes. Comparison of the HLA-DR results with those of two other prediction methods applied to the same data sets showed that MultiRTA achieved performance comparable to NetMHCIIpan and better than the earlier TEPITOPE method. We also directly tested model transferability by making leave-one-allele-out predictions for additional experimentally characterized sets of overlapping peptide epitopes binding to multiple MHC allotypes. In addition, we determined the applicability of prediction methods like MultiRTA to other MHC allotypes by examining the degree of MHC variation accounted for in the training set. An examination of predictions for the promiscuous binding CLIP peptide revealed variations in binding affinity among alleles as well as potentially distinct binding registers for HLA-DR and HLA-DP. Finally, we analyzed the optimal MultiRTA parameters to discover the most important peptide residues for promiscuous and allele-specific binding to HLA-DR and HLA-DP allotypes.</p> <p>Conclusions</p> <p>The MultiRTA method yields competitive performance but with a significantly simpler and physically interpretable model compared with previous prediction methods. A MultiRTA prediction webserver is available at <url>http://bordnerlab.org/MultiRTA</url>.</p>
url http://www.biomedcentral.com/1471-2105/11/482
work_keys_str_mv AT mittelmannhansd multirtaasimpleyetreliablemethodforpredictingpeptidebindingaffinitiesformultipleclassiimhcallotypes
AT bordnerandrewj multirtaasimpleyetreliablemethodforpredictingpeptidebindingaffinitiesformultipleclassiimhcallotypes
_version_ 1725190483942047744